BSX
Boston Scientific Corporation
NYSE · Healthcare · Medical - Devices · US
$47.84
+1.90%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
14.4x
EV/EBITDA
14.4x
Market Cap
$69.33B
MomentumView details →
1D Return
+1.90%
YTD Return
−50.45%
RSI (14)
45.0
ValuationView details →
P/E (Fwd)
14.4x
EV/EBITDA
14.4x
Market Cap
$69.33B
RSI (14)
45.0
MomentumView details →
1D Return
+1.90%
YTD Return
−50.45%
SummaryUpdated Jun 1, 2026
Boston Scientific Corporation (NYSE:BSX) is a leading global medical device company founded in 1979 and headquartered in Marlborough, Massachusetts. The company went public in 1992 and has since grown to become one of the world's largest medical technology companies, developing, manufacturing, and marketing medical devices used in various interventional medical specialties worldwide. Boston Scientific operates through three primary segments and has established itself as a major player in the medical device industry through both organic growth and strategic acquisitions.
Similar companies
Latest newsMore news →
The FDA posted three Class 2 recall records for Boston Scientific's LUX-Dx heart monitor server software due to a flaw that can delay atrial fibrillation alerts.15h agoBoston Scientific disclosed that a cyberattack on its IT systems, which began on August 25, 2026, is ongoing and is disrupting remote monitoring of implanted heart devices, including pacemakers and insertable cardiac monitors.4d agoBoston Scientific disclosed a cybersecurity incident that disrupted global operations, including information systems used to process and ship customer orders.9d ago